GJB2-MEDIATED HEARING LOSS

Clinical trials for GJB2-MEDIATED HEARING LOSS explained in plain language.

Never miss a new study

Get alerted when new GJB2-MEDIATED HEARING LOSS trials appear

Sign up with your email to follow new studies for GJB2-MEDIATED HEARING LOSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a single gene therapy injection restore hearing in deaf children?

⭐️ CURE ⭐️ Recruiting now

This study tests a new gene therapy, SKY-GJB2, for children aged 9 months to 7 years with hearing loss caused by changes in the GJB2 gene. The therapy is given as a single injection into the inner ear. Researchers will check if it is safe and if it can improve hearing. Ten childr…

Matched conditions: GJB2-MEDIATED HEARING LOSS

Phase: PHASE1, PHASE2 • Sponsor: Skylark Bio Inc. • Aim: ⭐️ CURE ⭐️

Last updated Jun 16, 2026 12:51 UTC

GJB2-MEDIATED HEARING LOSS

Get alerted when new GJB2-MEDIATED HEARING LOSS trials appear

Could a single gene therapy injection restore hearing in deaf children?